Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Rating of "Hold" by Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned an average recommendation of "Hold" from the five ratings firms that are presently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $16.10.

Several equities analysts have recently weighed in on MD shares. UBS Group increased their price objective on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a "neutral" rating in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Pediatrix Medical Group from a "buy" rating to a "hold" rating in a research note on Thursday, November 21st. Mizuho lifted their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group boosted their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a "buy" rating in a research report on Tuesday, November 5th.

Pediatrix Medical Group Stock Performance

NYSE MD traded up $0.10 on Friday, hitting $14.80. 404,413 shares of the stock were exchanged, compared to its average volume of 857,431. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The business's fifty day moving average is $13.66 and its 200 day moving average is $10.44. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $16.41. The company has a market capitalization of $1.27 billion, a PE ratio of -4.82, a P/E/G ratio of 2.10 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million for the quarter, compared to analyst estimates of $498.87 million. During the same period in the prior year, the firm posted $0.29 earnings per share. The company's quarterly revenue was up .9% compared to the same quarter last year. Research analysts anticipate that Pediatrix Medical Group will post 1.26 EPS for the current fiscal year.

Insider Transactions at Pediatrix Medical Group

In other news, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the sale, the executive vice president now owns 135,810 shares in the company, valued at $2,172,960. The trade was a 5.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the completion of the sale, the director now owns 138,683 shares of the company's stock, valued at $2,128,784.05. This represents a 16.60 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Pediatrix Medical Group

Institutional investors have recently made changes to their positions in the company. nVerses Capital LLC purchased a new position in shares of Pediatrix Medical Group in the 2nd quarter worth about $31,000. Innealta Capital LLC bought a new position in Pediatrix Medical Group during the second quarter valued at approximately $33,000. Quest Partners LLC boosted its stake in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after purchasing an additional 622 shares during the period. Nisa Investment Advisors LLC boosted its stake in shares of Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company's stock valued at $36,000 after purchasing an additional 1,524 shares during the period. Finally, Quarry LP boosted its stake in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,662 shares during the period. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.